Tag: investment
-
Venture Fund Formed to Back Longevity Research
A new venture capital fund is being formed to finance start-up companies developing technologies that aim to extend healthy human life spans.
-
Expanding Gel Pill Designed for Long-Term Diagnostics
An ingestible gel capsule is shown in tests with animals to expand and reside in the stomach for as long as a month for delivering drugs or monitoring bodily functions.
-
Start-Ups Saying No Thanks to Venture Capital
Yesterday, we reported on 2018 being a banner year for venture capital, but the New York Times says a movement of entrepreneurs is looking for other ways to raise money.
-
Infographic – Venture Finance Reaching Dot-Com Levels
Venture funding last year totaled $99.5 billion, the largest annual outlay since 2000.
-
Spin-Off Gains Seed Funds for Non-Opioid Pain Drug
A company spun-off from a university medical materials lab received start-up funds to develop a non-opioid surgical pain therapy, including a clinical trial.
-
Lilly Buys Precision Cancer Company in $8B Deal
Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body.
-
Infographic – Nasdaq Biotech Index Recovers
We’ll check in from time to time on the Nasdaq Biotechnology Index that tracks 223 biotech industry stocks.
-
Infographic – Tech IPOs Flat in 2018
CB Insights recently issued its annual Tech IPO Report, showing the number of initial public stock offerings in the technology industries unchanged from 2017.
-
Drug Discovery Start-Up Gains $400M Financing
A 2 year-old company using computational techniques to find protein-targeting drugs raised $400 million in new financing, led by the venture funding arm of Softbank.
-
Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal
Eli Lilly and Co. is licensing a a treatment candidate for Alzheimer’s disease from biopharmaceutical company AC Immune that aims to block accumulation of tau proteins in the brain.